Searched for
VAXZEVRIA
BJP has put lives of its countrymen at risk: SP chief Akhilesh Yadav on global withdrawal of CovishieldAkhilesh Yadav slams BJP for risking lives with AstraZeneca's global Covishield withdrawal due to excess supply. How will dangerous vaccine...- AstraZeneca to withdraw Covid vaccine globally as demand declines; faces legal challenges over side effectsAstrazeneca Vaccine: AstraZeneca has announced the worldwide withdrawal of its COVID-19 vaccine, Vaxzevria, citing a surplus of updated vac...
- Centre should urgently address alleged side-effects of Covishield, says Delhi health ministerUK-headquartered pharmaceutical giant AstraZeneca has admitted that in "very rare cases", its COVID-19 vaccine can cause a blood clot-relat...
- AstraZeneca profits fall, Covid vaccine sales slideNet profit slumped 64 percent to $746 million compared with the first six months of last year, AstraZeneca said in a statement. Operating e...
- AZ booster raises antibody levels against Omicron, says firmIt said that the increased response was observed in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, adding ...
- AstraZeneca vaccine booster shot effective against Omicron: Oxford lab studyThe Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the v...
- Testing a new jab on fresh strain, says AstraZenecaThe company, along with Oxford University, has developed a vaccine platform to enable it to respond quickly to new variants that may emerge.
- UK govt revises advisory, approves Covishield as qualified vaccine for travelIndia had earlier protested the UK's non-recognition of the Covishield vaccine and warned of “reciprocal measures” if the ‘discriminatory p...
- Nerve disorder listed as 'very rare' side effect of AstraZeneca jabGuillain-Barre Syndrome is a "very rare" side effect, occurring in under one in 10,000 people. The disorder is a nerve inflammation that ma...
- SII won't seek special marketing nod from EU body for vaxUK drug company, AstraZeneca, which developed the vaccine with Oxford University, has asked the regulator European Medicine Agency (EMA) to...
- AstraZeneca wants Serum Institute of India listed as manufacturing site“We have requested the addition of Serum Institute of India as an alternative manufacturing site on the Vaxzevria licence,” an AstraZeneca ...
- Serum Institute seeks 'Green Pass' approval for Covishield, applies to European agencyResponding to queries from ET, an EMA spokesperson confirmed on Monday that Covishield does not have marketing authorisation. "Even though ...
- Approval to Covishield would be considered should we receive marketing authorisation application: EU agencyThe EU Digital COVID certificate or 'Green Pass' will be mandatory to travel to European countries and the document is likely to serve as p...
- EU Green Pass: SII applies to EMA for inclusion of Covishield in approved jabs listThe EMA, which is the agency of the European Union responsible for the evaluation and supervision of medicinal products, has approved only ...
- India to take up Covishield absence from EU pass listIndia plans to strongly take up with the European Union (EU) the issue of non-inclusion of Serum Institute of India (SII)-manufactured Covi...
- No European Union 'Green Pass' for India-made Covishield, yetTravellers vaccinated with Covishield, manufactured by Pune-based Serum Institute of India (SII), may not be eligible for the European Unio...
- Delta variant now reported in 85 countries, expected to become dominant lineage, says WHOWHO said the four current 'Variants of Concern' being monitored closely - Alpha, Beta, Gamma and Delta - are widespread and have been detec...
- AstraZeneca, RDIF evince interest in Telangana's global tender for COVID-19 vaccineTelangana recently issued a globale-tendernotice for procuring ten million doses of COVID-19 vaccine from manufacturers or their agents in ...
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...
- AstraZeneca vaccine benefits increase with age: EU drug watchdogThe European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted ...
Load More
